Completed OBSERVATIONAL NCT05687474
Baby Detect : Genomic Newborn Screening (BabyDetect)
Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect
Sponsor: Centre Hospitalier Régional de la Citadelle
Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency Aciduria, Argininosuccinic Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of Adrenoleukodystrophy Alpha 1-Antitrypsin Deficiency Alpha-Thalassemia Alport Syndrome Andersen Tawil Syndrome Argininemia Aromatic L-amino Acid Decarboxylase Deficiency Ataxia With Vitamin E Deficiency Beta Ketothiolase Deficiency Biotinidase Deficiency Brain Dopamine-Serotonin Vesicular Transport Disease Branched-Chain Keto Acid Dehydrogenase Kinase Deficiency Carbamoyl Phosphate Synthase 1 Deficiency Carnitine Acylcarnitine Translocase Deficiency Carnitine Palmitoyltransferase Deficiency 1 Carnitine Palmitoyltransferase Deficiency 2 Catecholaminergic Polymorphic Ventricular Tachycardia Cerebral Folate Transport Deficiency Charcot-Marie-Tooth Disease, Type 6C Chediak-Higashi Syndrome Chronic Granulomatous Disease Citrullinemia 1 Citrullinemia Type II Cobalamin Deficiency Congenital Adrenal Hyperplasia Congenital Hypothyroidism Congenital Myasthenic Syndrome Congenital Nephrotic Syndrome, Finnish Type Creatine Deficiency Syndrome Crigler-Najjar Syndrome Cystic Fibrosis Cystinosis Deficiency of GOT2 Deficit in Anterior Pituitary Function and Variable Immunodeficiency Diamond Blackfan Anemia Disaccharide Intolerance I Dopamine Beta Hydroxylase Deficiency Familial Chylomicronemia Familial Hemophagocytic Lymphocytosis Familial Hyperinsulinemic Hypoglycemia 1 Familial Hypertrophic Cardiomyopathy Type 4 Fanconi Anemia Fanconi Bickel Syndrome Fructose-1,6-Diphosphatase Deficiency Fructosemia Galactosemias Gaucher Disease, Type 1 Glucose 6 Phosphate Dehydrogenase Deficiency Glucose Galactose Malabsorption Glut1 Deficiency Syndrome Glutaric Acidemia I Glycine Encephalopathy Glycogen Storage Disease Griscelli Syndrome Hemophilia A Hemophilia B Hereditary Hyperekplexia Hereditary Nephrogenic Diabetes Insipidus Hereditary Retinoblastoma Holocarboxylase Synthetase Deficiency Homocystinuria Hyperornithinemia-Hyperammonemia-Homocitrullinuria Hypophosphatasia, Infantile Inflammatory Bowel Disease 25, Autosomal Recessive Isolated Methylmalonic Acidemia Isovaleric Acidemia Jervell-Lange Nielsen Syndrome Late-Infantile Neuronal Ceroid Lipofuscinosis Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency Lysosomal Acid Lipase Deficiency Malonic Acidemia Maple Syrup Urine Disease Maturity Onset Diabetes of the Young Medium Chain Acyl CoA Dehydrogenase Deficiency Menkes Disease Metachromatic Leukodystrophy Mucopolysaccharidosis I Mucopolysaccharidosis II Mucopolysaccharidosis IV A Mucopolysaccharidosis VI Mucopolysaccharidosis VII N Acetyl Glutamate Synthetase Deficiency Ornithine Transcarbamylase Deficiency Phenylalanine Hydroxylase Deficiency Phosphoglucomutase 1 Deficiency Phosphoglycerate Dehydrogenase Deficiency Phosphoserine Aminotransferase Deficiency Phosphoserine Phosphatase Deficiency Pituitary Hormone Deficiency, Combined Pompe Disease Primary Hyperoxaluria Progressive Familial Intrahepatic Cholestasis Propionic Acidemia Pseudohypoaldosteronism Type 1 Pseudohypoaldosteronism, Type II Pyridoxine-5'-Phosphate Oxidase Deficiency Pyridoxine-Dependent Epilepsy Riboflavin Deficiency Riboflavin Transporter Deficiency S-Adenosylhomocysteine Hydrolase Deficiency Segawa Syndrome, Autosomal Recessive Sepiapterin Reductase Deficiency Severe Combined Immune Deficiency Severe Congenital Neutropenia Shwachman-Diamond Syndrome Sickle Cell Disease Smith-Lemli-Opitz Syndrome Succinyl-Coa:3-Ketoacid Coa-Transferase Deficiency Systemic Primary Carnitine Deficiency Thiamine Metabolism Dysfunction Syndrome 2 Thiamine Metabolism Dysfunction Syndrome 4 (Bilateral Striatal Degeneration and Progressive Polyneuropathy Type) Thiamine Metabolism Dysfunction Syndrome 5 (Episodic Encephalopathy Type) Thiamine-Responsive Megaloblastic Anemia Timothy Syndrome Transcobalamin Deficiency Tyrosinemia, Type I Very Long Chain Hydroxy Acyl Dehydrogenase Deficiency Wilson Disease Wiskott-Aldrich Syndrome X Linked Hypophosphatemia
Updated 8 times since 2023 Last updated: Aug 7, 2025 Started: Sep 1, 2022 Primary completion: Jun 2, 2025 Completion: Jun 2, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT05687474, this observational or N/A phase trial focuses on 3-Hydroxy 3-Methyl Glutaric Aciduria and 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency and remains completed. Sponsored by Centre Hospitalier Régional de la Citadelle, it has been updated 8 times since 2022, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2025 — Sep 2025 [monthly]
Recruiting
-
Mar 2025 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Mar 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
Nov 2023 — May 2024 [monthly]
Recruiting
-
Feb 2023 — Nov 2023 [monthly]
Recruiting
First recorded
Sep 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Centre Hospitalier Régional de la Citadelle
- Centre Hospitalier Universitaire de Liege
- Leon Fredericq Foundation
- Orchard Therapeutics
- Sanofi
- Takeda
- University of Liege
- Zentech-Lacar Company
Data source: Centre Hospitalier Universitaire de Liege
For direct contact, visit the study record on ClinicalTrials.gov .